Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swiss (SMI) Life Sciences Industry Analysis

UpdatedSep 04, 2026
DataAggregated Company Financials
Companies7
  • 7D-0.7%
  • 3M17.4%
  • 1Y3.6%
  • YTD12.8%

In the last week, Life Sciences has been flat. The past year has been better, since the industry has gained 3.6% in that time. Looking forward, earnings are forecast to grow by 19% annually.

Industry Valuation and Performance

Has the Swiss Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 04 Sep 2026CHF 55.0bCHF 10.6bCHF 1.3b39.5x42.1x5.2x
Sun, 02 Aug 2026CHF 53.4bCHF 10.5bCHF 1.3b37x42.3x5.1x
Tue, 30 Jun 2026CHF 51.1bCHF 10.1bCHF 1.1b39.1x46.8x5x
Thu, 28 May 2026CHF 48.7bCHF 10.1bCHF 1.1b39.4x44.7x4.8x
Sat, 25 Apr 2026CHF 45.9bCHF 10.1bCHF 1.1b34.2x40.2x4.5x
Mon, 23 Mar 2026CHF 44.0bCHF 10.1bCHF 1.1b31.1x38.5x4.3x
Wed, 18 Feb 2026CHF 50.1bCHF 10.1bCHF 1.3b31x39.3x5x
Fri, 16 Jan 2026CHF 52.4bCHF 10.6bCHF 1.1b33.1x47.7x4.9x
Sun, 14 Dec 2025CHF 47.0bCHF 10.6bCHF 1.1b27.6x42.8x4.4x
Tue, 11 Nov 2025CHF 48.3bCHF 10.6bCHF 1.1b27.7x43.9x4.5x
Thu, 09 Oct 2025CHF 50.6bCHF 10.6bCHF 1.1b32x46x4.7x
Sat, 06 Sep 2025CHF 53.3bCHF 10.6bCHF 1.1b33.5x48.4x5x
Mon, 04 Aug 2025CHF 54.2bCHF 10.7bCHF 1.1b34.6x47.2x5.1x
Wed, 02 Jul 2025CHF 52.6bCHF 10.1bCHF 1.0b33.3x50.7x5.2x
Fri, 30 May 2025CHF 52.3bCHF 10.1bCHF 1.0b31.6x50.3x5.2x
Sun, 27 Apr 2025CHF 52.4bCHF 10.1bCHF 1.0b29.7x50.5x5.2x
Tue, 25 Mar 2025CHF 53.6bCHF 10.1bCHF 1.0b33.4x52.6x5.3x
Thu, 20 Feb 2025CHF 56.2bCHF 10.1bCHF 1.0b35.5x55.8x5.6x
Sat, 18 Jan 2025CHF 54.0bCHF 10.2bCHF 943.3m34.9x57.3x5.3x
Mon, 16 Dec 2024CHF 53.1bCHF 10.2bCHF 943.5m38.6x56.3x5.2x
Wed, 13 Nov 2024CHF 56.5bCHF 10.2bCHF 943.5m43.4x59.9x5.5x
Fri, 11 Oct 2024CHF 53.7bCHF 10.2bCHF 943.5m41.1x57x5.3x
Sun, 08 Sep 2024CHF 55.6bCHF 10.2bCHF 937.2m43x59.3x5.4x
Tue, 06 Aug 2024CHF 56.1bCHF 10.2bCHF 924.4m43.6x60.7x5.5x
Thu, 04 Jul 2024CHF 53.2bCHF 10.3bCHF 1.0b45.7x53.1x5.2x
Sat, 01 Jun 2024CHF 52.2bCHF 10.3bCHF 1.0b43.9x52.1x5.1x
Mon, 29 Apr 2024CHF 55.2bCHF 10.3bCHF 1.0b43.8x55.1x5.4x
Wed, 27 Mar 2024CHF 57.7bCHF 10.3bCHF 1.0b46.3x57.6x5.6x
Fri, 23 Feb 2024CHF 50.2bCHF 10.2bCHF 982.4m46.7x51.1x4.9x
Sun, 21 Jan 2024CHF 41.2bCHF 9.8bCHF 1.5b30.8x27.6x4.2x
Tue, 19 Dec 2023CHF 41.2bCHF 9.8bCHF 1.5b32x27.6x4.2x
Thu, 16 Nov 2023CHF 41.0bCHF 9.8bCHF 1.5b28.8x27.5x4.2x
Sat, 14 Oct 2023CHF 45.6bCHF 9.8bCHF 1.5b30.4x30.5x4.7x
Mon, 11 Sep 2023CHF 51.9bCHF 9.8bCHF 1.5b35.7x34.8x5.3x
Price to Earnings Ratio

34.8x


Total Market Cap: CHF 51.9bTotal Earnings: CHF 1.5bTotal Revenue: CHF 9.8bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Life Sciences Industry Price to Earnings3Y Average 47.2x202420252026
Current Industry PE
  • Investors are pessimistic on the Swiss Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 42.1x which is lower than its 3-year average PE of 47.2x.
  • The industry is trading close to its 3-year average PS ratio of 5.0x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences industry have declined 4.3% per year over the last three years.
  • Meanwhile revenues for these companies have grown 2.7% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Swiss Healthcare industry?

CH Market-0.24%
Healthcare0.58%
Life Sciences-0.74%
Clinical Research and Equipment-0.74%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
BANB Bachem HoldingCHF 78.502.7%
+CHF 153.6m		23.5%PE39.5x
TECN Tecan GroupCHF 195.602.2%
+CHF 51.8m		26.5%PS2.8x

Latest News

TECN
CHF 195.60
Tecan Group
7D
2.2%
1Y
26.5%
Narrative Update • Sep 03

TECN: Margin Execution And 2028 Goals Will Shape Fairly Valued Outlook

Tecan Group's analyst price target has been revised higher, with the updated fair value estimate moving from CHF 175.48 to CHF 184.10 as analysts factor in recent target increases from UBS, Deutsche Bank and Morgan Stanley, along with a reduced future P/E assumption. Analyst Commentary Recent research on Tecan Group shows a mix of optimism on execution and caution on valuation, as reflected in a series of target price changes and rating moves over recent months.
XLS
CHF 13.20
Xlife Sciences
7D
-4.3%
1Y
-35.6%
LONN
CHF 582.00
Lonza Group
7D
-1.1%
1Y
0.7%
SFZN
CHF 70.75
Siegfried Holding
7D
-4.2%
1Y
-16.9%
Analysis Article • Aug 26

Earnings Miss: Siegfried Holding AG Missed EPS By 7.5% And Analysts Are Revising Their Forecasts

Last week, you might have seen that Siegfried Holding AG ( VTX:SFZN ) released its half-yearly result to the market...
SKAN
CHF 65.20
SKAN Group
7D
-2.1%
1Y
10.3%
BANB
CHF 78.50
Bachem Holding
7D
2.7%
1Y
23.5%